Analysts are divided when it comes to Johnson & Johnson (NYSE:JNJ) stock. The medical device company experienced its share of ups and downs this year. It is currently one of many companies attempting to defend itself against ongoing opioid lawsuits. In August, an Oklahoma judge found Johnson & Johnson guilty of deceptive marketing practices and fined the company $572 million. The company allegedly marketed its opioid products as non-addictive, in spite of repeated warnings from the FDA.
The question for investors is, how important is this verdict and what will the ongoing lawsuit mean for JNJ stock? Here are three things you need to know about the opioid lawsuits. JNJ has been around for more than 130 years and is the largest healthcare company in the world. The company actively participates in nearly every aspect of the healthcare industry. That includes making consumer products, selling medical equipment, and making and distributing pharmaceuticals. So JNJ is a company that’s built to last. The opioid lawsuits will cause short-term problems for the company. JNJ stock has remained relatively flat over the last year and is up 2.4% in 2019. But the company should persevere in spite of its challenges.
Source: InvestorPlace
Related Articles:
- Why Dividend Growth Stocks Are Evil
- 4 Higher-Yielding Financial Services Stocks With Rising Dividends
- 5 Higher Yield Dividend Growth Stocks
- Successful Investors Take The Emotion Out
- 5 Under-Valued Dividend Growth Stocks
3 Things Investors Should Know About the Opioid Lawsuits Against Johnson & Johnson
Posted by D4L | Friday, October 18, 2019 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
Dividend Growth Stocks News
~
Popular Posts Last 30 Days
-
If you're worried about inflation rearing its ugly head next year, you should probably worry about more likely catastrophes, such as bei...
-
As a relatively new blogger, the one thing that has stood out in my mind is the number of Canadian bloggers in the areas that I am most inte...
-
We screened our 24/7 Wall St. dividend equity research database and found 5 stocks that combined can generate over $3,000 of annual passive ...
-
The stock market has been on an upward path of late, with some of the most prominent stocks hitting astronomical highs. The dividend yield o...
-
Dividend growth stocks can be incredibly attractive investments if you crave recurring income. As these types of stocks raise their dividend...
-
In my opinion, there are three criteria investors should consider when evaluating a particular stock for their portfolio. The first is histo...
-
Dividends can be a tremendously powerful part of your investing strategy. Not only can they give you a continuing source of cash to reinvest...
-
In this article, we discuss 5 best March dividend stocks to buy. If you want to read our detailed analysis of dividend capture strategy and ...
-
As the broader stock rally broadens to some of the more “boring” corners of the market, it’s the higher-yielding dividend plays that could s...
-
Double your money in a short time. Few investors would walk away from such an opportunity. Of course, there's no guarantee that any inve...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.